glp-1 in type 2 diabetes

glp-1 in type 2 diabetes GLP-1-based therapies for diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Management of type 2 diabetes

Name: glp-1 in type 2 diabetes GLP-1-based therapies for diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Management of type 2 diabetes
Brand: desartech.ch
SKU: 12217914963
Price: 28.32 USD
Availability: InStock
Rating: 4.7452000000000005 (20 reviews)

SKU: 12217914963

4.7

EUR28.32 EUR48.32

Pay in 4 interest-free payments of $7.08 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Handling & Use (Laboratory Settings) Intended Use: Research use only

This initial period is all about adjustment

The distinct contributions of each receptor system - GLP-1-mediated improvements in insulin sensitivity and appetite regulation, GIP-mediated enhancement of insulin secretion and adipose tissue function, and glucagon-mediated direct hepatic metabolic modulation and increased energy expenditure - create synergistic benefits when engaged through dual or triple agonist formulations